MCMi Professional Development Activities
Through professional development activities, FDA meets the regulatory challenges posed by new science and technology developments. In addition to supporting a broad regulatory science program—including professional development components—FDA fosters collaborative activities with scientific institutions, academia, and industry.
Upcoming events
![Photo monrage of attendees participating in the annual training course where they learn best practices for ensuring data quality and integrity in mock BSL-4 facilities that shows a lab, a BSL-4 suit and a classroom.](https://public4.pagefreezer.com:443/content/FDA/13-03-2022T16:26/https://www.fda.gov/files/styles/medium_3/public/20191209_nonclinical_course_graphic.jpg?itok=d4oDU5X4)
Achieving Data Quality & Integrity in Maximum Containment Laboratories
April 25-29, 2022 - Annual course to help address challenges associated with ensuring data quality and integrity in regulated studies conducted in BSL-4 laboratories to support MCM development.
![Photo montage of students learning in a mock BSL-4 lab with and without BSL hazmat suits on.](https://public4.pagefreezer.com:443/content/FDA/13-03-2022T16:26/https://www.fda.gov/files/styles/medium_3/public/20191211_UTMB_clinical_course_graphic.jpg?itok=SHpY9pwV)
Data Quality & Integrity in Clinical Trials Involving High-Consequence Pathogens
2022 course dates coming soon - Annual course focused on the preparation and execution of research clinical trials to facilitate approval of MCMs for high-consequence pathogens.
events continued
![A participant in a data quality course conducts a training exercise wearing BSL-4 personal protective equipment.](https://public4.pagefreezer.com:443/content/FDA/13-03-2022T16:26/https://www.fda.gov/files/styles/medium_3/public/UTMB_labdemo3_1600px.jpg?itok=ApOI_gRe)
About MCMi Professional Development
Learn about training to help FDA and MCM developers meet regulatory challenges posed by new science and technology.
![News & events text shown on typewriter](https://public4.pagefreezer.com:443/content/FDA/13-03-2022T16:26/https://www.fda.gov/files/styles/medium_3/public/news-events-1600px_0.jpg?itok=LjJF8fiv)
MCMi news and events
News and events from the FDA Office of Counterterrorism and Emerging Threats (OCET), Medical Countermeasures Initiative (MCMi), and federal and industry partners.